Literature DB >> 20977397

Hypertension 2010: what was new for the cardiologist?

Zbigniew Gaciong1, Bartosz Symonides.   

Abstract

IMPORTANCE OF THE FIELD: Despite extensive clinical research, still there is some uncertainty regarding management of hypertension, in particular initial and goal blood pressure levels and selection of optimal pharmacotherapy, as well as concomitant medications, to reduce other risk factors. AREAS COVERED IN THIS REVIEW: An overview of recent findings from major clinical trials in hypertension (until July 2010), along with a reappraisal of the European Society of Hypertension 2009 guidelines. WHAT THE READER WILL GAIN: Practical overview of the management of hypertension, including threshold and goal blood pressure in specific situations, choice of antihypertensive medications and indications for treatment of concomitant risk factors. TAKE HOME MESSAGE: Primary benefits of antihypertensive therapy are mediated by blood pressure reduction and the majority of patients will require at least two drugs, with the preference of fixed-dose combinations for effective blood pressure control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977397     DOI: 10.1517/14656566.2010.513972

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  2 in total

Review 1.  Metabolic hypertension: concept and practice.

Authors:  Zhiming Zhu; Peijian Wang; Shuangtao Ma
Journal:  Front Med       Date:  2013-04-05       Impact factor: 4.592

2.  The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe.

Authors:  Agata Bielecka-Dabrowa; Wilbert S Aronow; Jacek Rysz; Maciej Banach
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.